Study on children with rare tumors
Part of Blood & lymphatic, Brain & nervous system, Cancer, Digestive system, Ear, nose & throat, Hormones & metabolism, Mouth & dental, Skin clinical trials.
This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 0 and 18 years old.
- You must have a very rare tumor that is either newly diagnosed or has come back after treatment.
- Your diagnosis and treatment must take place at a hospital or center taking part in this study.
- You or your parent/guardian must sign a form saying you understand and agree to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at rare or complex tumors in the chest, abdomen, or soft tissues. It aims to learn more about these uncommon cancers and how to best treat them.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
This study collects information from children and teens with rare solid tumors to better understand these cancers and support future research. You (or your guardian) can join by giving consent, but it’s mainly for people not already registered in certain ongoing pediatric cancer study databases in Germany.
This trial is creating a registry for very rare solid tumors in people up to age 39. Joining helps doctors learn more about these cancers and may connect you with future research opportunities.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
Hear when a new Paraganglioma/ Phaeochromocytoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.